Trump Admin Ends Federal Funding for Minors' Hormone Treatments and Surgeries

The Trump administration’s CMS announced that Medicaid and CHIP will stop funding gender-affirming care for minors, including cross-sex hormones, puberty blockers, and sex-change surgeries, with a six-month taper for current patients. Mental health treatments for gender dysphoria will continue to be covered. Officials say the procedures are experimental and carry long-term risks, citing the Cass Review, and frame the move as protecting children while saving taxpayer dollars.